Germinated brown rice regulates hepatic cholesterol metabolism and cardiovascular disease risk in hypercholesterolaemic rats

Journal of Functional Foods

Volumn 8, Issue 1, 2014, Pages 193-203

  Imam, Mustapha Umar ^a   Ishaka, Aminu ^a   Ooi, Der Jiun ^a   Zamri, Nur Diyana Md ^a   Sarega, Nadarajan ^a   Ismail, Maznah ^a   Esa, Norhaizan Mohd ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Cardiovascular disease; Germinated brown rice; Hepatic cholesterol metabolism; Oxidative stress; White rice

Indexed keywords

EID: 84899994579     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.03.013     Document Type: Article

References (49)

1. Almeida M., Ambrogini E., Han L., Manolagas S.C., Jilka R. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-γ expression, and diminished pro-osteogenic Wnt signaling in the skeleton. The Journal of Biological Chemistry 2009, 284(40):27438-27448.
2. Amano Y., Kawakubo K., Lee J.S., Tang A.C., Sugiyama M., Mori K. Correlation between dietary glycemic index and cardiovascular disease risk factors among Japanese women. European Journal of Clinical Nutrition 2004, 58:1472-1478.
3. Berg A.H., Scherer P.E. Adipose tissue, inflammation and cardiovascular disease. Circulation Research 2005, 96:939-949.
4. Bernabe J., Mulero J., Cerda B., Garcia-Viguera C., Moreno D.A., Parra S., Aviles F., Gil-Izquierdo A., Abellan J., Zafrilla P. Effects of a citrus based juice on biomarkers of oxidative stress in metabolic syndrome patients. Journal of Functional Foods 2013, 5(3):1031-1038.
5. Chen Z.-Y., Ma K.Y., Liang Y., Peng C., Zuo Y. Role and classification of cholesterol-lowering functional foods. Journal of Functional Foods 2011, 3(2):61-69.
6. Christou G.A., Kiortsis D.N. Adiponectin and lipoprotein metabolism. Obesity Reviews 2013, 14(12):939-949.
7. Cock T.-A., Houten S.M., Auwerx J. Peroxisome proliferator-activated receptor-γ: Too much of a good thing causes harm. EMBO Reports 2004, 5(2):142-147.
8. DeClercq V., Enns J.E., Yeganeh A., Taylor C.G., Zahradka P. Modulation of cardiovascular function by adipokines. Cardiovascular & Haematological Disorders - Drug Targets 2013, 13(1):59-72.
9. Delbosc S., Cristol J.-P., Descomps B., Mimran A., Jover B. Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress. Hypertension 2002, 40:142-147.
10. Demyen M., Alkhalloufi K., Pyrsopoulos N.T. Lipid-lowering agents and hepatotoxicity. Clinics in Liver Disease 2013, 17(4):699-714.
11. Du D., Shi Y.-H., Le G.-W. Oxidative stress induced by high-glucose diet in liver of C57BL/6J mice and its underlying mechanism. Molecular Biology Reports 2010, 37(8):3833-3839.
12. Esa N.M., Kadir K.-K.A., Amom Z., Azlan A. Antioxidant activity of white rice, brown rice and germinated brown rice (in vivo and in vitro) and the effects on lipid peroxidation and liver enzymes in hyperlipidaemic rabbits. Food Chemistry 2013, 141(2):1306-1312.
13. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Franco S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Huffman M.D., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Magid D., Marcus G.M., Marelli A., Matchar D.B., McGuire D.K., Mohler E.R., Moy C.S., Mussolino M.E., Nichol G., Paynter N.P., Schreiner P.J., Sorlie P.D., Stein J., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. Heart disease and stroke statistics - 2013 update. Circulation 2013, 127:e6-e245. American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
14. Harini M., Parama Astirin O.K.I.D. Blood cholesterol levels of hypercholesterolemic rat (Rattus norvegicus) after VCO treatment. Nusantara Bioscience 2009, (2):1.
15. Hasegawa H., Takano H., Komuro I. Therapeutic implications of PPARγ in cardiovascular diseases. PPAR Research 2010, 2010.
16. Ho J.N., Son M.E., Lim W.C., Lim S.T., Cho H.Y. Anti-obesity effects of germinated brown rice extract through down-regulation of lipogenic genes in high fat diet-induced obese mice. Bioscience, Biotechnology, and Biochemistry 2012, 76(6):1068-1074.
17. Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verhandelingen-Koninklijke Academie voor Geneeskunde van België 2008, 70(3).
18. Holvoet P., Keyzer D.D., Jacobs D.R. Oxidized LDL and the metabolic syndrome. Future Lipidology 2008, 3(6):637-649.
19. Hu E.A., Pan A., Malik V., Sun Q. White rice consumption and risk of type 2 diabetes: Meta-analysis and systematic review. British Medical Journal 2012, 344:e1454.
20. Hu Y., Tong G., Xu W., Pan J., Ryan K., Yang R., Shuldiner A.R., Gong D.W., Zhu D. Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis. Diabetes and Vascular Disease Research 2009, 6(4):262-268.
21. Imam M.U., Azmi N.H., Bhanger M.I., Ismail N., Ismail M. Antidiabetic properties of germinated brown rice: A systematic review. Evidence-based Complementary and Alternative Medicine 2012, 2012.
22. Imam M.U., Ismail M., Ithnin H., Tubesha Z., Omar A.R. Effects of germinated brown rice and its bioactive compounds on the expression of the peroxisome proliferator-activated receptor gamma gene. Nutrients 2013, 5(2):468-477.
23. Imam M.U., Ismail M., Omar A.R., Ithnin H. The hypocholesterolemic effect of germinated brown rice involves the upregulation of the apolipoprotein A1 and low-density lipoprotein receptor genes. Journal of Diabetes Research 2013, 2013.
24. Imam M.U., Maznah I. Nutrigenomic effects of germinated brown rice and its bioactives on hepatic gluconeogenic genes in type 2 diabetic rats and HEPG2 cells. Molecular Nutrition and Food Research 2013, 57(3):401-411.
25. Imam M.U., Musa S.N.A., Azmi N.H., Ismail M. Effects of white rice, brown rice and germinated brown rice on antioxidant status of type 2 diabetic rats. International Journal of Molecular Sciences 2012, 13:12952-12969.
26. Jacobs D.R., Gross M.D., Tapsell L.C. Food synergy: An operational concept for understanding nutrition. The American Journal of Clinical Nutrition 2009, 89(5):1543S-1548S.
27. Jacobs D.R., Tapsell L.C. Food, not nutrients, is the fundamental unit in nutrition. Nutrition Reviews 2007, 65(10):439-450.
28. Keaney J.F., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., Benjamin E.J. Obesity and systemic oxidative stress clinical correlates of oxidative stress in the Framingham Study. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 23(3):434-439. Framingham Study.
29. Kim J.K., Fillmore J.J., Chen Y., Yu C., Moore I.K., Pypaert M., Lutz E.P., Kako Y., Velez-Carrasco W., Goldberg I.J., Breslow J.L., Shulman G.I. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proceedings of the National Academy of Sciences 2001, 98(13):7522-7527.
30. Lee C.H., Olson P., Evans R.M. Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003, 144(6):2201-2207.
31. Lennerz B.S., Alsop D.C., Holsen L.M., Stern E., Rojas R., Ebbeling C.B., Goldstein J.M., Ludwig D.S. Effects of dietary glycemic index on brain regions related to reward and craving in men. The American Journal of Clinical Nutrition 2013, 98:641-647.
32. Leon A.S., Bronas U.G. Dyslipidemia and risk of coronary heart disease: Role of lifestyle approaches for its management. American Journal of Lifestyle Medicine 2009, 3:257-273.
33. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., Franklin B., Kris-Etherton P., Harris W.S., Howard B., Karanja N., Lefevre M., Rudel L., Sacks F., Van Horn L., Winston M., Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82-96.
34. Marchi E.D., Baldassari F., Bononi A., Wieckowski M.R., Pinton P. Oxidative stress in cardiovascular disease and obesity: Role of p66Shc and protein kinase C. Oxidative Medicine and Cellular Longevity 2013, 2013.
35. Munzel T., Gori T., Bruno R.M., Taddei S. Is oxidative stress a therapeutic target in cardiovascular disease?. European Heart Journal 2010, 31(22):2741-2749.
36. Ooi D.-J., Iqbal S., Ismail M. Proximate composition, nutritional attributes and mineral composition of Peperomia pellucida L. (Ketumpangan Air) grown in Malaysia. Molecules 2012, 17:11139-11145.
37. Oram J.F., Vaughan A.M. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circulation Research 2006, 99:1031-1043.
38. Otarod J.K., Goldberg I.J. Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk. Current Atherosclerosis Reports 2004, 6(5):335-342.
39. Parikh P., McDaniel M.C., Ashen D., Miller J.I., Sorrentino M., Chan V., Blumenthal R.S., Sperling L.S. Diets and cardiovascular disease: An evidence-based assessment. Journal of the American College of Cardiology 2005, 45(9):1379-1387.
40. Pi-Sunyer X., Blackburn G., Brancati F.L., Bray G.A., Bright R., Clark J.M., Curtis J.M., Espeland M.A., Foreyt J.P., Graves K., Haffner S.M., Harrison B., Hill J.O., Horton E.S., Jakicic J., Jeffery R.W., Johnson K.C., Kahn S., Kelley D.E., Kitabchi A.E., Knowler W.C., Lewis C.E., Maschak-Carey B.J., Montgomery B., Nathan D.M., Patricio J., Peters A., Redmon J.B., Reeves R.S., Ryan D.H., Safford M., Van Dorsten B., Wadden T.A., Wagenknecht L., Wesche-Thobaben J., Wing R.R., Yanovski S.Z. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: One-year results of the Look AHEAD trial. Diabetes Care 2007, 30:1374-1383. Look AHEAD Research Group.
41. Qin Y.-W., Ye P., He J.-Q., Sheng L., Wang L.-Y., Du J. Simvastatin inhibited cardiac hyperthrophy and fibrosis in apolipoprotein E-deficient mice fed a 'Western-style diet' by increasing PPAR α and γ expression and reducing TC, MMP-9, and Cat S levels. Acta Pharmacologica Sinica 2010, 31:1350-1358.
42. Renaud S.C. Dietary management of cardiovascular diseases. Prostaglandins, Leukotrienes, and Essential Fatty Acids 1997, 57(4):423-427.
43. Schuck R.N., Mendys P.M., Simpson Jr.R.J. Beyond statins: Lipid management to reduce cardiovascular risk. Pharmacotheraphy 2013, 33(7):754-764.
44. Scicchitano P., Cameli M., Maiello M., Modesti P.A., Muiesan M.L., Novo S., Palmiero P., Saba P.S., Pedrinelli R., Ciccone M.M. Nutraceuticals and dyslipidaemia: Beyond the common therapeutics. Journal of Functional Foods 2014, 6:11-32.
45. Shen Y., Yang T., Guo S., Li X., Chen L., Wang T., Wen F. Increased serum ox-LDL levels correlated with lung function, inflammation, and oxidative stress in COPD. Mediators of Inflammation 2013, 2013.
46. Soffler C., Campbell V.L., Hassel D.M. Measurement of urinary F2-isoprostanes as markers of in vivo lipid peroxidation: A comparison of enzyme immunoassays with gas chromatography-mass spectrometry in domestic animal species. Journal of Veterinary Diagnostic Investigation 2010, 22(2):200-209.
47. Van Horn L., McCoin M., Kris-Etherton P.M., Burke F., Carson J.A.S., Champagne C.M., Karmally W., Sikand G. The evidence for dietary prevention and treatment of cardiovascular disease. Journal of the American Dietetic Association 2008, 108(2):287-331.
48. Wang J., Chen Y., Zhang W., Zheng G., Meng S., Che H., Ke T., Yang J., Chen J., Luo W. Akt activation protects liver cells from apoptosis in rats during acute cold exposure. International Journal of Biological Sciences 2013, 9(5):509-517.
49. Xu A., Vanhoutte P.M. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. American Journal of Physiology, Heart and Circulatory Physiology 2012, 302:H1231-H1240.